Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alhussaini, A."'
Autor:
Abdul K. Siraj, Sandeep Kumar Parvathareddy, Padmanaban Annaiyappanaidu, Wael Haqawi, Maha Al-Rasheed, Hadeel M. AlManea, Hussah F. AlHussaini, Fouad Al-Dayel, Khawla S. Al-Kuraya
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 2, p 73 (2021)
Several clinical trials are investigating the use of immune-targeted therapy with Programmed death ligand-1 (PD-L1) inhibitors for colorectal cancer (CRC), with promising results for patients with mismatch repair (MMR) deficiency or metastatic CRC. H
Externí odkaz:
https://doaj.org/article/9d02eb70a29c4a158ac7f7ccd989e149
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fouad Al-Dayel, Hussah F AlHussaini, Sandeep Kumar Parvathareddy, Wael Haqawi, Maha Al-Rasheed, Khawla S Al-Kuraya, Padmanaban Annaiyappanaidu, Abdul K. Siraj, Hadeel Al-Manea
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 2
Journal of Personalized Medicine, Vol 11, Iss 73, p 73 (2021)
Volume 11
Issue 2
Journal of Personalized Medicine, Vol 11, Iss 73, p 73 (2021)
Several clinical trials are investigating the use of immune-targeted therapy with Programmed death ligand-1 (PD-L1) inhibitors for colorectal cancer (CRC), with promising results for patients with mismatch repair (MMR) deficiency or metastatic CRC. H